Publications | Lucence 6/8

top of page

Publications

Filter by:

Whole-genome sequencing identifies responders to Pembrolizumab in relapse/refractory natural-killer/T cell lymphoma

Publications

2020年8月5日

Whole-genome sequencing identifies responders to Pembrolizumab in relapse/refractory natural-killer/T cell lymphoma

Whole-genome sequencing identifies responders to Pembrolizumab in relapse/refractory natural-killer/T cell lymphoma

Ultrasensitive detection of diverse genomic alterations in hematological malignancies using a targeted amplicon-based sequencing approach

Publications

2020年6月1日

Ultrasensitive detection of diverse genomic alterations in hematological malignancies using a targeted amplicon-based sequencing approach

Ultrasensitive detection of diverse genomic alterations in hematological malignancies using a targeted amplicon-based sequencing approach

A discrete choice experiment (DCE) study evaluating preferences of Asian adults for inherited cancer risk testing.

Publications

2020年5月25日

A discrete choice experiment (DCE) study evaluating preferences of Asian adults for inherited cancer risk testing.

A discrete choice experiment (DCE) study evaluating preferences of Asian adults for inherited cancer risk testing.

Clinical utility of a liquid biopsy diagnostic approach in lung cancer using amplicon-based next-generation sequencing in parallel with allele-specific PCR.

Publications

2020年5月25日

Clinical utility of a liquid biopsy diagnostic approach in lung cancer using amplicon-based next-generation sequencing in parallel with allele-specific PCR.

Clinical utility of a liquid biopsy diagnostic approach in lung cancer using amplicon-based next-generation sequencing in parallel with allele-specific PCR.

Detection of actionable gene mutations in breast cancer by amplicon-based next-generation sequencing liquid biopsy

Publications

2020年5月25日

Detection of actionable gene mutations in breast cancer by amplicon-based next-generation sequencing liquid biopsy

Detection of actionable gene mutations in breast cancer by amplicon-based next-generation sequencing liquid biopsy

An ultrasensitive amplicon-based sequencing panel for noninvasive molecular testing of hematological malignancies using blood.

Publications

2020年5月25日

An ultrasensitive amplicon-based sequencing panel for noninvasive molecular testing of hematological malignancies using blood.

An ultrasensitive amplicon-based sequencing panel for noninvasive molecular testing of hematological malignancies using blood.

Ultrasensitive multiplex detection of structural rearrangements in ALK, RET, ROS1 and PD-L1 using a comprehensive next-generation sequencing assay.

Publications

2020年5月25日

Ultrasensitive multiplex detection of structural rearrangements in ALK, RET, ROS1 and PD-L1 using a comprehensive next-generation sequencing assay.

Ultrasensitive multiplex detection of structural rearrangements in ALK, RET, ROS1 and PD-L1 using a comprehensive next-generation sequencing assay.

Prognostic and predictive value of circulating tumour DNA (ctDNA) by amplicon-based next generation sequencing (NGS) of advanced pancreatic cancer (APC) in a phase I trial of oxaliplatin capecitabine and irinotecan (OXIRI) triplet chemotherapy.

Publications

2020年2月4日

Prognostic and predictive value of circulating tumour DNA (ctDNA) by amplicon-based next generation sequencing (NGS) of advanced pancreatic cancer (APC) in a phase I trial of oxaliplatin capecitabine and irinotecan (OXIRI) triplet chemotherapy.

Prognostic and predictive value of circulating tumour DNA (ctDNA) by amplicon-based next generation sequencing (NGS) of advanced pancreatic cancer (APC) in a phase I trial of oxaliplatin capecitabine and irinotecan (OXIRI) triplet chemotherapy.

Genetic Characterization of Vietnamese Patients with Hereditary Breast and Ovarian Cancer Syndrome

Publications

2018年11月18日

Genetic Characterization of Vietnamese Patients with Hereditary Breast and Ovarian Cancer Syndrome

Genetic Characterization of Vietnamese Patients with Hereditary Breast and Ovarian Cancer Syndrome

1

/

8

bottom of page